TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
In Chronic Renal Failure (CRF) patients with primary glomerular disease or nephrosclerosis as
the primary disease:
- To confirm the superiority of TRK-100STP over placebo
- To determine the recommended therapeutic dose in the 2 doses of TRK-100STP
- To assess the safety of TRK-100STP